NATR Stock Forecast & Price Target

Natures Sunshine Products Inc. demonstrated a positive growth trajectory with 2025 sales reaching $480.1 million, which reflects a 5.7% increase and aligns with management's guidance. The company reported a notable improvement in gross margin, increasing by 190 basis points year-over-year to 73.3%, driven by cost-saving initiatives and favorable product mix. Additionally, the European segment posted a robust 10.0% growth in constant currency, bolstered by strong execution and enhanced product availability, particularly in Eastern Europe, indicating a solid foundation for future expansion.

Nature’s Sunshine Products Inc. faces a negative outlook primarily due to declining sales in its key market, Asia, which experienced a 1% year-over-year decrease attributed to challenging comparisons following a significant 21% growth in the previous quarter. Additionally, the company's higher selling, general, and administrative (SG&A) expenses, which showed deleveraging to 39.1% of sales, raise concerns about profitability and overall financial efficiency. The potential for further sales declines is heightened by the risks associated with product innovation and reputation management, particularly as consumers may shift towards lower-cost options in the competitive vitamins and supplements sector.